Table 2.

Clinical characteristics and experimental information for AML patients

Patients	Cell source	Age at diagnosis	Sex	WBS count [10^9/L]	Cytogenetic anomalies
1	BM	50	F	116.6	46, XX[20]
2	BM	20	M	190.2	46, XY[20]
3	BM	33	M	2.78	46, XY, t(6;9) (p23;q34) [18] /46, xy[2]
4	BM	71	M	2.33	46, XY[20]
5	BM, PB	62	M	61.47	46, XY[20]
6	PB	41	M	208.55	46, XY, t(9;22) (q34;q11,2) [2] /53, idem, + 3, + 8, + 10, + 10, + 15, + 19, + der(22)t9;22)[18]
7	PB	84	M	345.38	45,X, -Y[20]
8	PB	59	M	10.84	46,XY, inv(16) (p13,1q22) [20]
9	PB	52	F	406.24	46, XX, t(9;22) (q34;q11,2) [18] /47, idem, + 19[2]
10	PB	47	M	335.41	46, XY, inv(9) (p12q13) [20]